Alcohol Use Disorders in Alcoholic Liver Disease.


Journal

Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002

Informations de publication

Date de publication:
02 2019
Historique:
entrez: 21 11 2018
pubmed: 21 11 2018
medline: 17 9 2019
Statut: ppublish

Résumé

Alcohol use disorder (AUD) is common in alcoholic liver disease (ALD) and intrinsic to its pathophysiology. Optimal treatment requires a multidisciplinary team approach and a working alliance between patients and providers. Diagnosing AUD involves a combination of thorough history taking, physical examination, screening questionnaires, and alcohol biomarkers. Alcohol biomarkers have advantages and limitations of use of which clinicians should be aware. AUD treatment is effective, multifaceted, and can be tailored to each individual. Available treatment modalities are myriad: motivational enhancement therapy, cognitive behavior therapy, 12-step facilitation, group therapies, intensive outpatient programs, inpatient and residential treatment, and relapse prevention medications.

Identifiants

pubmed: 30454833
pii: S1089-3261(18)30080-1
doi: 10.1016/j.cld.2018.09.004
pii:
doi:

Substances chimiques

Alcohol Deterrents 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-69

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Jessica L Mellinger (JL)

Division of Gastroenterology and Hepatology, Michigan Medicine, 1500 East Medical Center Drive, SPC 5334, Ann Arbor, MI 48109, USA. Electronic address: jmelling@med.umich.edu.

Gerald Scott Winder (GS)

Department of Psychiatry, Michigan Medicine, 1500 East Medical Center Drive, SPC 5118, Ann Arbor, MI 48109, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH